Stellaromics, a start-up that uses multiomics technology to help researchers understand the spatial organization of cells and tissues, has raised $80 million in a series B financing. Catalyst4, a ...
For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...
TD Cowen downgraded Illumina Inc (NASDAQ:ILMN) to "Hold" following the company's fourth-quarter earnings, citing weaker-than-expected next-generation sequencing (NGS) consumable growth, increasing ...
Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, ...
Illumina Inc (NASDAQ:ILMN). reported stronger-than-expected earnings for the fourth quarter of 2024, with both earnings per share (EPS) and revenue surpassing analysts' forecasts. Despite the positive ...
Core Illumina revenue of $1.1 billion for Q4 2024, up 1% from Q4 2023 on both a reported and constant currency basis; revenue of $4.3 billion for fiscal year 2024, down 2% from fiscal year 2023 on ...
Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory for Digestive Health, National Clinical Research Center for Digestive Disease, Beijing ...
Illumina's set of platforms NovaSeq, NextSeq, MiSeq, iSeq, as well as NovaSeq X-series, are optimized for a number of throughput possibilities, from modest research to expansive clinical and ...
Originally published on Illumina News CenterIllumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention di ...
The Illumina MiSeq i100 Series, announced last fall ... company calls "universal software"-meaning that the MiSeq i100 and NovaSeq X leverage many of the same software components, even though ...
The Illumina MiSeq i100 Series, announced last fall ... and building what the company calls“universal software”-meaning that the MiSeq i100 and NovaSeq X leverage many of the same software components, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results